Golden Ocean Group Limited
GOGL - Transactions made under the buy-back program
GOGL - Transactions made under the buy-back program
Reference is made to the stock announcement on October 2, 2024, where Golden Ocean Group Limited (OSE/NASDAQ: GOGL) announced the renewal of its share buy-back program of maximum USD 100 million to purchase up to an aggregate of 10,000,000 of the company's common shares in a 12 months period from the announcement.
Golden Ocean Group Limited (“GOGL” or the “Company”) announces that the Company has between December 20, 2024, and December 23, 2024, purchased 80,000 of the Company’s own common stocks on the Oslo Stock Exchange at an average price of NOK 99.15 per share. Following the completion of the above transactions, GOGL owns a total of 1,787,328 of own shares, corresponding to 0.89% of the Company’s share capital.
An overview of all transactions made under the buy-back program that have been carried out during the above-mentioned date is attached to this report and available at www.newsweb.no.
December 30, 2024
Hamilton, Bermuda
For more info please contact:
Peder Simonsen, Interim Chief Executive Officer and Chief Financial Officer of Golden Ocean Management AS.
Telephone +47 23 11 40 00
This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.
Forward-looking statements: This release and any materials distributed in connection with this release may contain certain forward-looking statements. By their nature, forward-looking statements involve risk and uncertainty because they reflect the Company’s current expectations and assumptions as to future events and circumstances that may not prove accurate. A number of material factors could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements.
Attachments
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
MoonLake Immunotherapeutics AG25.4.2025 22:05:00 CEST | Press release
MoonLake Immunotherapeutics to host a Capital Markets Day on Tuesday, April 29
T-knife Therapeutics25.4.2025 19:00:00 CEST | Press release
T-knife Therapeutics Presents Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting Demonstrating a Potential Best-in-Class PRAME Targeted TCR-T Therapy
Zymeworks Inc.25.4.2025 19:00:00 CEST | Press release
Zymeworks Presents New Data from Multiple Development Programs at 2025 AACR Annual Meeting
Sequana Medical NV25.4.2025 18:00:00 CEST | Press release
Press release: Transparency Notification from Shareholders
Sanoma Corp25.4.2025 17:30:00 CEST | Press release
SANOMA CORPORATION: ACQUISITION OF OWN SHARES 25 April 2025
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom